Triton Wealth Management, Pllc Harvard Bioscience Inc Transaction History
Triton Wealth Management, Pllc
- $186 Million
- Q4 2024
A detailed history of Triton Wealth Management, Pllc transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Triton Wealth Management, Pllc holds 10,884 shares of HBIO stock, worth $5,115. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,884
Previous 12,344
11.83%
Holding current value
$5,115
Previous $33,000
33.33%
% of portfolio
0.01%
Previous 0.02%
Shares
12 transactions
Others Institutions Holding HBIO
# of Institutions
96Shares Held
26.2MCall Options Held
8.7KPut Options Held
2K-
Amh Equity LTD3.39MShares$1.59 Million3.14% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.34 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.19MShares$1.03 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$1.01 Million0.0% of portfolio
-
Royce & Associates LP1.78MShares$835,6100.01% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $19.6M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...